Intra Uterine Ball News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(1) The trial assesses the safety and efficacy of the IUB SEAD, a disruptive treatment for AUB. In this study, 50% of the participating patients have reached the End of the Study point, demonstrating a significant reduction in bleeding, avoiding the need to undergo invasive uterine ablation procedures or even a hysterectomy MODIIN, Israel, March 4, 2021 /PRNewswire/ OCON Healthcare, a women s health company which develops, manufactures and commercializes an innovative 3D intrauterine drug delivery technology based on its patented IUB TM (Intra Uterine Ball) platform, today announced it had completed enrollment of its Phase IIa clinical study evaluating its intrauterine drug delivery platform IUB SEAD,a non-invasive treatment for abnormal uterine bleeding (AUB).

Israel generalRavit levrannKostenloser wertpapierhandelSergio haimovichIntra uterine ballAbnormal uterine bleedingChief medical officerHealth careஇஸ்ரேல் ஜநரல்இன்ட்ரா கருப்பை பந்துஇயல்பு கடந்த கருப்பை இரத்தப்போக்குதலைமை மருத்துவ அதிகாரிஆரோக்கியம் பராமரிப்புஇயல்பு கடந்த